News

  • Stephanie Bryant, professor of chemical and biological engineering, stands beside a seated colleague in a laboratory, observing a computer screen displaying microscope images while using a microscope workstation with lab equipment and sample containers nearby.
    A С»ÆÊé Boulder-led team has developed a suite of new therapies aimed at reversing osteoarthritis in a single injection. With animal studies showing promise and funding from the Advanced Research Projects Agency for Health extended, the team could be ready for human trials by 2028. Professor Stephanie Bryant is the principal investigator of the project.
  • Kristi Anseth
    Distinguished Professor Kristi Anseth has received theÌýBiomaterials Global Impact Award, which recognizes distinguished research and development accomplishments in the field of biomaterials. Anseth is known for developing tissue substitutes that improve treatments for conditions like broken bones and heart valve disease.
  • An AI generated illustration of a liver. Adobe Stock photo
    С»ÆÊé Boulder researchers and partners at MIT, Harvard and Columbia are working to recreate the human liver’s complex structure in the lab. With support from a $25 million ARPA-H grant, the team aims to develop 3D-printed, transplantable liver tissue made from human cells that the body won’t reject. Professor Jason Burdick's lab at С»ÆÊé’s BioFrontiers Institute will lead the 3D printing component of the project.
  • Microscopy images comparing cell behavior in different hydrogels. Columns labeled “no cells,” “viscoelastic,” and “elastic” show green hydrogel shapes (circle, square, triangle). In viscoelastic hydrogels, purple mesenchymal stromal cells spread and deform the green matrix. In elastic hydrogels, the purple cells remain confined and clustered without spreading. Scale bar: 500 micrometers.
    A new light-controlled hydrogel developed at С»ÆÊé Boulder mimics the movement and flexibility of real tissue, giving scientists a more realistic way to study cells and disease. The work was recently published in the journal Matter and was directed by Distinguished Professor Kristi Anseth.
  • Assistant Professor Laurel Hind’s lab discovered how certain immune cells can suppress the body’s response to infection, using advanced human cell models.
  • Erin Dunphy in a v-neck sweater and shoulder-length hair
    Dunphy's research involves studying interactions at the atomic level to design more efficient catalysts for polymer upcycling, an innovative approach for converting plastic wastes into valuable products, such as jet fuels.
  • Thad Sauvain wearing glasses and a casual open-neck shirt with buildings blurred in the background
    Thad Sauvain (ChemEngr’91) recently established a legacy endowment in his estate plan to support undergraduate scholarships for С»ÆÊé Boulder chemical and mechanical engineering majors, with preference for those who demonstrate a commitment to the LGBTQ+ community. Sauvain credits his own time at С»ÆÊé Boulder, where he earned a BS in chemical engineering, with helping him thrive both as an engineer and as a gay individual.
  • Arianna McCarty with long hair and a building blurred in the background.
    Chemical and biological engineering senior Arianna McCarty has earned the prestigious Churchill Scholarship, becoming just the fourth student in university history to receive the honor. The award will support a year of master’s study at the University of Cambridge, recognizing her exceptional research achievements and academic excellence.
  • Dragan Mejic in a black open-neck black shirt against a dark blue background.
    Dragan Mejic is the Instrument Shop Supervisor for Chemical and Biological Engineering, whose expert machining, welding and equipment design directly support student learning and cutting-edge faculty research. A trusted, positive presence in the department, he also advocates for state employees through volunteer leadership with the Secure PERA coalition.
  • Wyatt Shields
    Assistant Professor Wyatt Shields along with other researchers have developed a safer, targeted way to deliver an ovarian cancer drug using immune cell–carried particles, supported by $300,000 in Gates Institute funding to advance it toward clinical use.
Subscribe to News